Tuberculosis Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube Formation in Macrophages
Shanti Souriant,
Luciana Balboa,
Maeva Dupont,
Karine Pingris,
Denise Kviatcovsky,
Céline Cougoule,
Claire Lastrucci,
Aicha Bah,
Romain Gasser,
Renaud Poincloux,
Brigitte Raynaud-Messina,
Talal Al Saati,
Sandra Inwentarz,
Susana Poggi,
Eduardo Jose Moraña,
Pablo González-Montaner,
Marcelo Corti,
Bernard Lagane,
Isabelle Vergne,
Carolina Allers,
Deepak Kaushal,
Marcelo J. Kuroda,
Maria del Carmen Sasiain,
Olivier Neyrolles,
Isabelle Maridonneau-Parini,
Geanncarlo Lugo-Villarino,
Christel Vérollet
Affiliations
Shanti Souriant
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina
Luciana Balboa
International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina; Institute of Experimental Medicine–CONICET, National Academy of Medicine, Buenos Aires, Argentina
Maeva Dupont
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina
Karine Pingris
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
Denise Kviatcovsky
International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina; Institute of Experimental Medicine–CONICET, National Academy of Medicine, Buenos Aires, Argentina
Céline Cougoule
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina
Claire Lastrucci
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; Centre for Genomic Regulation, Barcelona, Spain
Aicha Bah
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
Romain Gasser
Centre de Physiopathologie de Toulouse Purpan, INSERM UMR 1043, CNRS UMR 5282, Université Toulouse III Paul Sabatier, Toulouse, France
Renaud Poincloux
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
Brigitte Raynaud-Messina
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
Talal Al Saati
INSERM/UPS/ENVT–US006/CREFRE, Service d’Histopathologie, CHU Purpan, 31024 Toulouse, France
Sandra Inwentarz
Instituto de Tisioneumonologia “Raúl F. Vaccarezza,” Universitad de Buenos Aires, Argentina
Susana Poggi
Instituto de Tisioneumonologia “Raúl F. Vaccarezza,” Universitad de Buenos Aires, Argentina
Eduardo Jose Moraña
Instituto de Tisioneumonologia “Raúl F. Vaccarezza,” Universitad de Buenos Aires, Argentina
Pablo González-Montaner
Instituto de Tisioneumonologia “Raúl F. Vaccarezza,” Universitad de Buenos Aires, Argentina
Marcelo Corti
Division de SIDA, Hospital de Infecciosas Dr. F.J. Muñiz, Buenos Aires, Argentina
Bernard Lagane
Centre de Physiopathologie de Toulouse Purpan, INSERM UMR 1043, CNRS UMR 5282, Université Toulouse III Paul Sabatier, Toulouse, France
Isabelle Vergne
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France
Carolina Allers
Tulane National Primate Research Center, Covington, LA 70433, USA; Department of Microbiology and Immunology, School of Medicine, Tulane University, New Orleans, LA 70112, USA
Deepak Kaushal
Tulane National Primate Research Center, Covington, LA 70433, USA; Department of Microbiology and Immunology, School of Medicine, Tulane University, New Orleans, LA 70112, USA
Marcelo J. Kuroda
Tulane National Primate Research Center, Covington, LA 70433, USA; Department of Microbiology and Immunology, School of Medicine, Tulane University, New Orleans, LA 70112, USA
Maria del Carmen Sasiain
International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina; Institute of Experimental Medicine–CONICET, National Academy of Medicine, Buenos Aires, Argentina
Olivier Neyrolles
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina
Isabelle Maridonneau-Parini
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina
Geanncarlo Lugo-Villarino
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina; Corresponding author
Christel Vérollet
Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France; International Associated Laboratory (LIA) CNRS “IM-TB/HIV” (1167), Toulouse, France, and Buenos Aires, Argentina; Corresponding author
Summary: The tuberculosis (TB) bacillus, Mycobacterium tuberculosis (Mtb), and HIV-1 act synergistically; however, the mechanisms by which Mtb exacerbates HIV-1 pathogenesis are not well known. Using in vitro and ex vivo cell culture systems, we show that human M(IL-10) anti-inflammatory macrophages, present in TB-associated microenvironment, produce high levels of HIV-1. In vivo, M(IL-10) macrophages are expanded in lungs of co-infected non-human primates, which correlates with disease severity. Furthermore, HIV-1/Mtb co-infected patients display an accumulation of M(IL-10) macrophage markers (soluble CD163 and MerTK). These M(IL-10) macrophages form direct cell-to-cell bridges, which we identified as tunneling nanotubes (TNTs) involved in viral transfer. TNT formation requires the IL-10/STAT3 signaling pathway, and targeted inhibition of TNTs substantially reduces the enhancement of HIV-1 cell-to-cell transfer and overproduction in M(IL-10) macrophages. Our study reveals that TNTs facilitate viral transfer and amplification, thereby promoting TNT formation as a mechanism to be explored in TB/AIDS potential therapeutics. : Tuberculosis is a clear, yet confounding, risk factor for HIV-1-induced morbidity and mortality. In this issue, Souriant et al. reveal that a tuberculosis-associated microenvironment triggers IL-10/STAT3-dependent tunneling nanotube formation in M(IL-10) macrophages, which promotes HIV-1 exacerbation during co-infection. M(IL-10) macrophage accumulation is also observed in vivo in co-infected subjects. Keywords: AIDS, HIV-1, tuberculosis, Mycobacterium tuberculosis, co-infection, macrophage, monocyte, IL-10, STAT3, viral spread, tunneling nanotubes, biomarker